Protagonist Therapeutics Inc buy Wedbush
Start price
19.11.24
/
50%
€50.50
Target price
19.11.25
€54.82
Performance (%)
46.53%
End price
20.11.25
€74.00
Summary
This prediction ended on 20.11.25 with a price of €74.00. With a performance of 46.53% the BUY prediction by Wedbush was a big success. Wedbush has a follow-up prediction for Protagonist Therapeutics Inc where he still thinks Protagonist Therapeutics Inc is a Buy. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Protagonist Therapeutics Inc | - | - | - |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Wedbush for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $58.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat
In the thread Trading Protagonist Therapeutics Inc
Die von Wedbush gewählte maximale Laufzeit wurde überschritten
Current prediction by Wedbush for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€50.50
12.03.25
12.03.25
-
12.03.26
12.03.26
46.53%
03.12.25
03.12.25
Stopped prediction by Wedbush for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€66.00
28.10.25
28.10.25
€73.77
28.10.26
28.10.26
12.12%
03.12.25
03.12.25
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€44.40
28.03.25
28.03.25
€64.84
28.03.26
28.03.26
66.67%
03.12.25
03.12.25